Literature DB >> 31378369

MiR-143-3p directly targets GLUT9 to reduce uric acid reabsorption and inflammatory response of renal tubular epithelial cells.

Zhichao Zhou1, Ya Dong1, Hanchi Zhou1, Jia Liu1, Wei Zhao2.   

Abstract

GLUT9 is generally considered to be associated with the uric acid transport, which plays an important role in the regulation of serum uric acid level. In this study, the expression level of miR-143-3p was significantly decreased in hyperuricemia mice model group compared with the normal control by miRNA microarray, the same results were confirmed in the hyperuricemia patients and the healthy control group. It is predicted that GLUT9 may be the target gene of miR-143-3p by target scan and other net-software. GLUT9 as the downstream target gene of miR-143-3p was determinated by fluorescence enzyme activity assay. Western blotting and qRT-PCR indicated that the expression of GLUT9 in human renal tubular epithelial cells transfected with miR-143-3p mimics was significantly reduced. Meanwhile inflammatory factors IL-1β and MCP-1 significantly decreased. In conclusion, miR-143-3p can reduce uric acid reabsorption by inhibiting its downstream target gene GLUT9.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GLUT9; Hyperuricemia; Inflammatory response; MicroRNA; Uric acid reabsorption

Mesh:

Substances:

Year:  2019        PMID: 31378369     DOI: 10.1016/j.bbrc.2019.07.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury.

Authors:  Hong-Yong Su; Chen Yang; Dong Liang; Hua-Feng Liu
Journal:  Biomed Res Int       Date:  2020-06-26       Impact factor: 3.411

Review 2.  Role of microRNA alternation in the pathogenesis of gouty arthritis.

Authors:  Zhipan Luo; Fan Yang; Shaocheng Hong; Jianpeng Wang; Bangjie Chen; Liangyun Li; Junfa Yang; Yan Yao; Chenchen Yang; Ying Hu; Shuxian Wang; Tao Xu; Jun Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

3.  Circulating microRNA alternations in primary hyperuricemia and gout.

Authors:  Jana Bohatá; Veronika Horváthová; Markéta Pavlíková; Blanka Stibůrková
Journal:  Arthritis Res Ther       Date:  2021-07-10       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.